206852-91-7

Basic information

• Product Name: Acetic acid (3aR,4R,6R,6aR)-6-[1-{2-[2-(2-azido-ethoxy)-ethoxy]-ethyl}-2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester
• Synonyms: Acetic acid (3aR,4R,6R,6aR)-6-[1-{2-[2-(2-azido-ethoxy)-ethoxy]-ethyl}-2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester
• CAS NO: 206852-91-7
• Molecular Weight: 777.837
• Mol File: 206852-91-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Acetic acid (3aR,4R,6R,6aR)-6-[1-{2-[2-(2-azido-ethoxy)-ethoxy]-ethyl}-2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid (3aR,4R,6R,6aR)-6-[1-{2-[2-(2-azido-ethoxy)-ethoxy]-ethyl}-2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester(206852-91-7)
• EPA Substance Registry System: Acetic acid (3aR,4R,6R,6aR)-6-[1-{2-[2-(2-azido-ethoxy)-ethoxy]-ethyl}-2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester(206852-91-7)

Safety Data

• Hazardous Substances Data: 206852-91-7(Hazardous Substances Data)

Upstream product

• 199003-62-8 N,N-Dibenzyl-N'-[9-((3aR,4R,6R,6aR)-6-hydroxymethyl-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-formamidine 
• 14042-37-6 9-(2',3'-O-benzylidene-β-D-ribofuranosyl)guanine 
• 118-00-3 G 
• 100-52-7 benzaldehyde 
• 86520-52-7 2-[2-(2-azidoethoxy)ethoxy]ethanol 
• 206852-90-6 Acetic acid (3aR,4R,6R,6aR)-6-[2-(dibenzylamino-methyleneamino)-6-oxo-1,6-dihydro-purin-9-yl]-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester 

Downstream Products

• 206852-94-0 C₆₆H₆₈N₁₀O₁₂P₂ 
• 206852-93-9 N'-[1-{2-[2-(2-Azido-ethoxy)-ethoxy]-ethyl}-9-((3aR,4R,6R,6aR)-6-hydroxymethyl-2-phenyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-N,N-dibenzyl-formamidine 

Relevant articles and documents

Synthesis of a functionalized GDP-analogue designed for anti-GDP antibody production

An enzymatically stable analogue of GDP is prepared in 7 steps starting from guanosine. The guanine moiety is functionalized at the N-1 position so as to allow anchoring of the nucleotide onto a carrier protein for subsequent immunization of animals in order to raise antibodies against GDP.